Company: EUDAW
Filing Date: 2025-06-24
Form Type: 424B5
Source: 0001641172-25-016185
Chunk: 13

Company: EUDA Health Holdings Ltd
Filing Date: 2025-06-24
Form: 424B5
Chunk 13
---
 they find attractive.

The trading price of our ordinary shares may fluctuate widely as a result of a number of factors, many of which are outside our control. In addition, the stock market is subject to fluctuations in the share prices and trading volumes that affect the market prices of the shares of many companies. These broad market fluctuations could adversely affect the market price of our ordinary shares. Among the factors that could affect our stock price are:

| ● | uncertainties                                                                                              
 and risks relating to the Company’s recent strategic shift from medical services to the wellness industry; |

| ● | the                                                                                                                     
 ability to successfully integrate newly acquired businesses, adopt a new business model, and add new service offerings; |

| ● | risks                                                                                                                                  
 relating to direct sales of stem cell therapies rendered by third parties in China, and the litigation and regulatory risks associated 
 with that;                                                                                                                             |

| ● | reliance                                                                                                                          
 on agreements or strategic relationships with third parties who have developed the technological solutions offered by the Company 
 or the distribution rights to the services offered by the Company;                                                                |

| ● | geopolitical                                                                                                                      
 risk and changes in applicable laws or regulations, and regional economic, regulatory, and competitive risks in different markets 
 in Southeast Asia;                                                                                                                |

| ● | the                                                                                                                               
 accuracy of our projections and estimates regarding our expenses, capital requirements, cash utilization, and need for additional 
 financing;                                                                                                                        |

| ● | expectations                                                                                                                         
 regarding the Company’s strategies and future financial performance, including its future business plans or objectives, prospective  
 performance and opportunities and competitors, revenues, products, pricing, operating expenses, market trends, liquidity, cash flows 
 and uses of cash, capital expenditures;                                                                                              |

| ● | the                                                                           
 ability to invest in growth initiatives and pursue acquisition opportunities; |

| ● | risks                                                                                                                            
 related to having a relatively new management team with limited experience of working together and of managing a public company; |

| S-7 |

| ● | concentration                                                                     
 of share ownership and limited liquidity and trading of the Company’s securities; |

| ● | the                                                                         
 ability to maintain the listing of the Company’s ordinary shares on Nasdaq; |

| ● | the                                                                                                                 
 possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and |

| ● | litigation                                                                                                                   
 and regulatory risks, including the diversion of management’s time and attention and the additional costs and demands on the 
 Company’s resources.                                                                                                         |

We have broad discretion in the use of